@OlympiaReport. Zacks: Analysts Expect Evoke Pharma Inc $EVOK Will Post Earnings of -$0.05 Per Share https://t.co/EZFuvmJX9e. March 28th 2020, 3:03pm Results 1 - 10 of 127 Overview · Press Releases · SEC Filings · Stock Information · Historic Stock 27, 2020 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), PDUFA Target Goal Date is June 19, 2020 SOLANA BEACH, Calif. , Jan. Granted 180- Day Extension by Nasdaq Regarding Minimum Bid Price. 17 Sep 2019 Evoke Pharma stock could close above $1 for the first time in months and $787.1 million in revenue -- both of which beat analysts' estimates. Fiscal Period Ending, Revenue Estimate, FWD Price/Sales, Low, High, # of Analysts. Dec 2019, 0.00, -, 0.00, 0.00, 1. Dec 2020, 0.00, -, 0.00, 0.00, 1. Earnings 13 Jan 2014 Evoke Pharma (NASDAQ:EVOK) is perhaps such a biotech stock. article prior to analyzing potential price targets for this undervalued stock. HSIL Share Price, HSIL Stock Price, HSIL Ltd. Stock/Share prices, HSIL Ltd. Live BSE/NSE, F&O Quote of HSIL Ltd. with Historic price charts for NSE / BSE.
Apr 03, 2020 · Evoke Pharma, Inc. (EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal diseases, today announced that on November 29, 2019, it received notification from the Listing Qualifications Department of the Nasdaq Stock Market that the Company has regained compliance with the minimum bid price requirement under Nasdaq
Evoke Pharma Analysts: This is the Analysts-site for the company Evoke Pharma on Markets Insider NASDAQ:EVOK Evoke Pharma, Inc. Stock Analysis - CapitalCube Evoke Pharma, Inc. operates as a pharmaceutical company, which focuses on the development of drugs to treat gastrointestinal, or GI, disorders and diseases. Selected Notes From Wall Street Analysts On Evoke Pharma ... Jan 22, 2020 · Additionally, EVOK shares got another “Buy” rating from FBR & Co., setting a target price of $10 on the company’s shares, according to the report published in October 19th, 2017. On March 16th, 2017, Rodman & Renshaw Reiterated an Buy rating and increased its price target from $6 to $9. Evoke Pharma (NASDAQ:EVOK) Stock Price Up 5.8% - Dakota ... Evoke Pharma Inc (NASDAQ:EVOK)’s share price rose 5.8% on Tuesday . The stock traded as high as $1.47 and last traded at $1.46, approximately 101,326 shares traded hands during trading. A decline of 56% from the average daily volume of 232,792 shares. The stock had previously closed at $1.38. EVOK has been the topic of […]
Nov 06, 2019 · Evoke Pharma Inc. analyst estimates by MarketWatch. View EVOK revenue estimates and earnings estimates, as well as analyst recommendations.
Nov 08, 2019 · Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
EVOK Stock Price, Forecast & News (Evoke Pharma) | MarketBeat
Based on analysts offering 12 month price targets for EVOK in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. Sign in to your
Market Data by Xignite and BATS BZX Real-Time Price. Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk,
Evoke Pharma, Inc. Common Stock (EVOK) Analyst Research ... Based on analysts offering 12 month price targets for EVOK in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. Sign in to your EVOK - Evoke Pharma Inc Stock quote - CNNMoney.com Find real-time EVOK - Evoke Pharma Inc stock quotes, company profile, news and forecasts from CNN Business. EVOK - Evoke Pharma Inc Stock quote - CNNMoney.com Markets Evoke Pharma, Inc. (EVOK) Analyst Ratings, Estimates ... See Evoke Pharma, Inc. (EVOK) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
Evoke Pharma, Inc. Common Stock (EVOK) Real-Time Stock ... EVOK's NASDAQ Last Sale (NLS) "Last Sale" is the price at which a stock last traded during regular market hours. NLS Volume "Volume" is the number of shares of the stock traded on the listing exchange during regular trading hours. Previous Close Today's High / Low 52 Week High / Low Evoke Pharma, Inc. - EVOK - Stock Price Today - Zacks